Long-term cardiac safety and outcomes of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC) Meeting Abstract


Authors: Dang, C. T.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R.; Steingart, R.; Norton, L.; Hudis, C.
Abstract Title: Long-term cardiac safety and outcomes of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880300082
DOI: 10.1200/jco.2011.29.15_suppl.579
PROVIDER: wos
Notes: Meeting Abstract: 579 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Patrick Glyn Morris
    116 Morris
  3. Clifford Hudis
    905 Hudis
  4. Larry Norton
    758 Norton
  5. Chau Dang
    271 Dang
  6. Richard M Steingart
    174 Steingart
  7. Carol Chen
    40 Chen
  8. Alyson Merced
    13 Merced
  9. Robert James Lehman
    10 Lehman